REVERSAL OF MULTIDRUG-RESISTANCE TO CANCER-CHEMOTHERAPY

被引：0
|
作者：
LEYLANDJONES, B
DALTON, W
FISHER, GA
SIKIC, BI
机构：
[1] UNIV ARIZONA,ARIZONA CANC CTR,TUCSON,AZ 85721
[2] STANFORD UNIV,MED CTR,STANFORD,CA 94305
来源：
CANCER | 1993年 / 72卷 / 11期
关键词：
MULTIDRUG RESISTANCE; CALCIUM CHANNEL BLOCKERS; CYCLOSPORINES;
D O I：
10.1002/1097-0142(19931201)72:11+<3484::AID-CNCR2820721615>3.0.CO;2-L
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In the past few years, the role of membrane-bound transport genes in human disease has been increasingly recognized and understood. Of these genes, the p170 membrane glycoprotein may function as an outward transport pump for many cancer chemotherapeutic drugs associated with the multidrug resistance phenotype. This article reviews the different classes of the current major modulators of multidrug resistance.
引用
收藏
页码：3484 / 3488
页数：5
相关论文
共 50 条
  • [31] MULTIDRUG-RESISTANCE - A PROBLEM IN CANCER-TREATMENT
    SOBERON, ML
    RODRIGUEZ, RB
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1993, 45 (05): : 481 - 492
  • [32] SOME THOUGHTS ON RESISTANCE TO CANCER-CHEMOTHERAPY
    CARTER, SK
    [J]. CANCER TREATMENT REVIEWS, 1984, 11 : 3 - 7
  • [33] CELLULAR-RESISTANCE TO CANCER-CHEMOTHERAPY
    SKOVSGAARD, T
    NIELSEN, D
    MAARE, C
    WASSERMANN, K
    [J]. INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 156, 1994, 156 : 77 - 157
  • [34] REVERSAL OF THE HUMAN AND MURINE MULTIDRUG-RESISTANCE PHENOTYPE WITH MEGESTROL-ACETATE
    WANG, L
    YANG, CPH
    HORWITZ, SB
    TRAIL, PA
    CASAZZA, AM
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (02) : 96 - 102
  • [35] STRUCTURE-ACTIVITY RELATIONSHIP OF VERAPAMIL ANALOGS AND REVERSAL OF MULTIDRUG-RESISTANCE
    TOFFOLI, G
    SIMONE, F
    CORONA, G
    RASCHACK, M
    CAPPELLETTO, B
    GIGANTE, M
    BOIOCCHI, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (08) : 1245 - 1255
  • [36] ACQUIRED-RESISTANCE TO CANCER-CHEMOTHERAPY
    SELBY, P
    [J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6426): : 1252 - 1253
  • [37] MULTIDRUG-RESISTANCE IN LYMPHOMAS
    YUEN, AR
    SIKIC, BI
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) : 2453 - 2459
  • [38] Reversal of multidrug-resistance using Valspodaro® (PSC 833) and doxorubicin in osteosarcoma
    Cagliero, E
    Ferracini, R
    Morello, E
    Scotlandi, K
    Manara, MC
    Buracco, P
    Comandone, A
    Parisi, RB
    Baldini, N
    [J]. ONCOLOGY REPORTS, 2004, 12 (05) : 1023 - 1031
  • [39] IS THERE A ROLE FOR RESISTANCE MODIFIERS IN CANCER-CHEMOTHERAPY
    PLUMB, JA
    MILROY, R
    KAYE, SB
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 473 - 473
  • [40] REVERSAL OF MULTIDRUG-RESISTANCE PHENOTYPE BY SURFACTANTS - RELATIONSHIP TO MEMBRANE LIPID FLUIDITY
    DUDEJA, PK
    ANDERSON, KM
    HARRIS, JS
    BUCKINGHAM, L
    COON, JS
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (01) : 309 - 315
12345